UnitedHealth Group (UNH) Earnings Analysis

UnitedHealth Group (UNH) next reports earnings on 2026-10-27, consensus EPS 4.06 USD. Last quarter (2026-07-16) it beat with EPS 6.38 USD vs 4.94 USD est (+29.1%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E 27.74.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does UNH next report earnings?

Next earnings date2026-10-27
Consensus EPS estimate4.06 USD
Revenue estimate111.32B

UNH earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-07-166.38 USD4.94 USD+29.1%Beat
2026-04-217.23 USD6.46 USD+11.9%Beat
2026-01-272.11 USD2.1 USD+0.5%Beat
2025-04-177.2 USD7.29 USD-1.2%Miss
2025-01-166.81 USD6.74 USD+1%Beat
2024-10-157.15 USD7 USD+2.1%Beat

Beat rate: 5/6 (83%) over reported quarters with consensus data.

UNH valuation and analyst view

Trailing P/E27.74
Trailing EPS15.587 USD
Price / book3.74
Dividend yield2.08%
Market cap392.45B
Analyst consensusBuy (43 buy / 7 hold / 2 sell)
Avg price target472.21 USD

Related research pages

Frequently asked questions

When is UnitedHealth Group (UNH)'s next earnings date?

UnitedHealth Group is next scheduled to report on 2026-10-27, with a consensus EPS estimate of 4.06 USD and revenue estimate of 111.32B.

Did UNH beat earnings last quarter?

In its 2026-07-16 report, UNH posted EPS of 6.38 USD versus a 4.94 USD estimate — a beat of 29.1%.

What is UNH's earnings track record?

Over the last 6 reported quarters with consensus data, UNH beat estimates 5 times (83%).

What is UNH's current P/E ratio and EPS?

UNH trades at a trailing P/E of 27.74 on trailing EPS of 15.587248081395414 USD.

What do analysts rate UNH?

Analyst consensus is "Buy" across 52 ratings (0 strong buy, 43 buy, 7 hold, 2 sell, 0 strong sell). Average 12-month price target: 472.21 USD.